Pages that link to "Q38427211"
Jump to navigation
Jump to search
The following pages link to Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes (Q38427211):
Displaying 50 items.
- Bone Marrow-Derived Stem Cells: a Mixed Blessing in the Multifaceted World of Diabetic Complications (Q26749552) (← links)
- Uncovering heart failure with preserved ejection fraction in patients with type 2 diabetes in primary care: time for a change (Q26767122) (← links)
- Facts and updates about cardiovascular non-coding RNAs in heart failure (Q28072307) (← links)
- Diabetic Cardiomyopathy: Does the Type of Diabetes Matter? (Q28079593) (← links)
- Diabetes and Clinical and Subclinical CVD. (Q30244573) (← links)
- Pharmacotherapy for comorbidities in chronic heart failure: a focus on hematinic deficiencies, diabetes mellitus and hyperkalemia (Q30250020) (← links)
- Diagnostic approaches for diabetic cardiomyopathy. (Q30362092) (← links)
- Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study. (Q33660548) (← links)
- Effects of 1,25-dihydroxyvitamin D3 on pathological changes in rats with diabetic cardiomyopathy (Q33781356) (← links)
- Diabetic retinopathy is associated with diastolic dysfunction in type 2 diabetic patients with non-ischemic dilated cardiomyopathy. (Q33882472) (← links)
- Constraints on Biological Mechanism from Disease Comorbidity Using Electronic Medical Records and Database of Genetic Variants (Q35999356) (← links)
- Relationship between Regional Fat Distribution and Hypertrophic Cardiomyopathy Phenotype (Q36070076) (← links)
- Silent diabetic cardiomyopathy in everyday practice: a clinical and echocardiographic study (Q36205861) (← links)
- Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations (Q37011769) (← links)
- Cardiac Computed Tomography Angiographic Findings as Predictors of Late Heart Failure in an Asymptomatic Diabetic Cohort: An 8-Year Prospective Follow-Up Study (Q38619761) (← links)
- Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs). (Q38626688) (← links)
- Apigenin alleviates STZ-induced diabetic cardiomyopathy (Q38717398) (← links)
- Novel insight into the dangerous connection between diabetes and heart failure (Q38806574) (← links)
- Reframing the association and significance of co-morbidities in heart failure (Q38881287) (← links)
- Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention (Q39201286) (← links)
- Coronary microvascular dysfunction in diabetes mellitus (Q39393549) (← links)
- MicroRNA and hyperglycemic memory in the diabetic heart (Q39716987) (← links)
- Association of Cardiovascular Risk Factors and Myocardial Fibrosis With Early Cardiac Dysfunction in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (Q40420450) (← links)
- Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction (Q41025346) (← links)
- Pyrrolidine dithiocarbamate ameliorates endothelial dysfunction in thoracic aorta of diabetic rats by preserving vascular DDAH activity (Q41034679) (← links)
- Type 2 diabetes mellitus correlates with systolic function during myocardial stress perfusion scanning with Nitrogen-13 ammonia PET. (Q41310265) (← links)
- Cathepsin K knockout protects against cardiac dysfunction in diabetic mice (Q41458755) (← links)
- Rutin administration attenuates myocardial dysfunction in diabetic rats (Q41713255) (← links)
- Metabolic cardiomyopathies - fighting the next epidemic (Q42050369) (← links)
- Role of Vitamin D in Cardiovascular Diseases (Q46209230) (← links)
- Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1. (Q47122148) (← links)
- Restrictive Cardiomyopathies: The Importance of Noninvasive Cardiac Imaging Modalities in Diagnosis and Treatment-A Systematic Review (Q47162150) (← links)
- Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women? (Q47571604) (← links)
- Comorbidities in Heart Failure (Q47744924) (← links)
- Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy (Q47763435) (← links)
- Left atrium passive ejection fraction is the most sensitive index of type 2 diabetes mellitus-related cardiac changes (Q48105315) (← links)
- Clinical impact of oral antidiabetic medications in heart failure patients. (Q48188587) (← links)
- Relationship of biomarkers of extracellular matrix with myocardial function in Type 2 diabetes mellitus. (Q48207488) (← links)
- Human heart failure with preserved ejection versus feline cardiomyopathy: what can we learn from both veterinary and human medicine? (Q48247164) (← links)
- Monoamine oxidase-dependent endoplasmic reticulum-mitochondria dysfunction and mast cell degranulation lead to adverse cardiac remodeling in diabetes (Q49830046) (← links)
- Interrelationship between diabetes mellitus and heart failure: the role of peroxisome proliferator-activated receptors in left ventricle performance. (Q49908591) (← links)
- High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report (Q50100662) (← links)
- Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study (Q51735896) (← links)
- Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology (Q51742440) (← links)
- Echocardiographic feature of diabetic cardiomyopathy: where are we now? (Q52654959) (← links)
- The complex principle of cause and effect. (Q53110004) (← links)
- Cats with diabetes mellitus have diastolic dysfunction in the absence of structural heart disease. (Q54387818) (← links)
- Ultrasonographic Characterization of the db/db Mouse: An Animal Model of Metabolic Abnormalities. (Q55282928) (← links)
- Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology (Q57180762) (← links)
- Favorable outcomes of metformin on coronary microvasculature in experimental diabetic cardiomyopathy (Q57468938) (← links)